Bright Green Stock (NASDAQ:BGXX)

Revenue Ownership Financials Chart

Previous Close

$0.07

52W Range

$0.03 - $0.54

50D Avg

$0.12

200D Avg

$0.21

Market Cap

$17.48M

Avg Vol (3M)

$732.99K

Beta

-0.26

Div Yield

-

BGXX Company Profile

Bright Green Corporation grows, manufactures, and sells cannabis and cannabis-related products legally under federal and state laws for research, pharmaceutical applications, and export. The company was incorporated in 2019 and is based in Fort Lauderdale, Florida.

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

5

IPO Date

May 17, 2022

Website

BGXX Performance

BGXX Financial Summary

	Dec 23	Dec 22	Dec 21
Revenue	$401.49K	$203.55K	-
Operating Income	$-10.79M	$-27.31M	$-2.49M
Net Income	-	$-28.09M	$-2.49M
EBITDA	$-10.79M	$-26.40M	$-1.74M
Basic EPS	-	$-0.17	$-0.02
Diluted EPS	-	$-0.17	$-0.02

Fiscal year ends in Dec 23 | Currency in USD

Peer Comparison

Ticker	Company
ORGO	Organogenesis Holdings Inc.
CGC	Canopy Growth Corporation
SNDL	SNDL Inc.
ALIM	Alimera Sciences, Inc.
SHPH	Shuttle Pharmaceuticals Holdings, Inc.
PTPI	Petros Pharmaceuticals, Inc.
LSDI	Lucy Scientific Discovery Inc.
OGI	OrganiGram Holdings Inc.
ACB	Aurora Cannabis Inc.
SXTC	China SXT Pharmaceuticals, Inc.
CRON	Cronos Group Inc.